Journal of Gastroenterology

Article	Citations
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom	130
Bifidobacterium bifidum CIP-01 attenuates metabolic dysfunction-associated steatotic liver disease induced by high-alcohol-producing Klebsiella pneumoniae	83
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy	80
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv	78
Reelin level in serum-derived extracellular vesicles predicts regression of M2BPGi-defined liver fibrosis following hepatitis C virus eradication by direct-acting antiviral agents	72
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma	60
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease	60
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	57
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy	52
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers	44
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism	43
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus	42
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis	41
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study	39
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan	38
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan	38
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data	37
Single-cell transcriptomics unveils the immunologic landscape of anti-PD-1-associated indirect drug-induced liver injury	35
Pathophysiology, assessment, and treatment of pain in patients with pancreatic ductal adenocarcinoma	35
Regional disparities in pancreaticoduodenectomy mortality: more than just rurality?	35
Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis	35
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy	34
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial	32
Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens	32
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices	32

Clinicopathological features of localized-type IgG4-related cholecystitis: a nationwide multicenter study in Japan	31
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database	31
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials	30
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis	30
Clinical practice guidelines for duodenal cancer 2021	30
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study	27
Acknowledgements	27
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan	26
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan	25
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?	24
Correction: Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)	24
Clinical significance of gadoxetate sodium-enhanced MRI for detecting liver metastasis in patients with pancreatic cancer: decadal real-world data analysis in Japan	24
Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study	24
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis	23
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation	23
Evaluating liver reserve in direct-acting antiviral-treated hepatitis C patients: do we have better surrogate markers?	22
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey	22
Clinical relevance of the identification of the distal end of the palisade vessel in cases with columnar-lined esophagus: a comment on the study by Hatta et al.	22
Letter to “Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis”	21
SEVs-carried ENPP1 regulates DCs’ activation and inhibits the formation of tertiary lymphoid structures in gastric cancer	21
Comment on: Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease	21
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)	21
Clinical characteristics of acute pancreatitis in patients with inflammatory bowel disease: a nationwide survey in Japan	21
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021	20
Dependence-related screening positivity among regular stimulant-laxative users with chronic constipation: a multicenter prospective observational study	20
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis	20
Is it necessary for endoscopic surveillance for achalasia patients?	19
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma	19
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study	19
Inhibiting METTL3 synergizes with Notch blockade to treat ESCC by targeting cancer stemness via m6A-JAG2	19
Hypoxia-mediated chromatin accessibility reprogramming of CA9 induces treatment resistance in colorectal mucinous adenocarcinoma	19
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study	18
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia	18
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19	17
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”	17
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer	17
Volatomics-based biomarkers for non-invasive diagnosis and monitoring of inflammatory bowel disease	17
VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway	16
Letter to the editor to ‘‘Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis’’	16
An interpretable machine learning model for predicting survival in pancreatic cancer via SHAP: a multicenter study	16
Clinicopathological features and prognosis of metastatic tumors in the small bowel: a large multicenter analysis of the JSCCR database in Japan	16
The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study	16
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection	16
Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma	16
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?	15
Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study	15
Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nationwide clinical database	15
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”	15
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic	15
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)	15

Checking the shape of hepatocellular carcinoma: how irregular is irregular?	15
Clinical applications of gut microbiome for non-invasive diagnosis of colorectal neoplasia	15
Molecular imaging of gastrointestinal stromal tumor using anti-c-KIT antibody and its fragments	15
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis	15
Conditional accuracy after lesion preselection: comment on Minakata et al.	15
Management of MASLD/MASH: challenges, innovations, and the future of patient-centered care in Japan	15
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases	15
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma	15
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society	14
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry	14
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation	14
Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn’s disease in Japan in 2023	14
HLA-DQB1*03:01 and HLA-DQA1*05:05 as key genetic determinants of infliximab response and immunogenicity in Japanese patients with inflammatory bowel disease	14
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases	14
AI-assisted diagnosis of Helicobacter pylori infection: strengths, limitations, and future directions	14
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease	14
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development	13
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance	13
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	13
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance	13
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy	13
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention	13
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy	13
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy	12
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia	12
Reply to “Comment on: Long-term evaluation of Helicobacter pylori screening in school health checkups: an 11-year study in Japan”	12
Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study	12
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2021	12
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis	12
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	11
Comment on “A novel artificial intelligence-based endoscopic ultrasonography diagnostic system for diagnosing the invasion depth of early gastric cancer”	11
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study	11
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation	11
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer	11
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co	11
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	11
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis	11
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data	11
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando	11
Chemotherapy-induced cell cycle arrest is associated with increased claudin-18 isoform 2 expression and enhanced zolbetuximab-mediated cytotoxicity in gastric cancer	11
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	11
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma	11
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan	11
Acknowledgements	11
Comment on “Risk of extraintestinal cancer in patients with inflammatory bowel disease: a multicenter retrospective cohort study in Japan”	11
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis	10
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease	10
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"	10
The antiferroptotic effect of indigo on ulcerative colitis	10
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer	10
Targeting the ZDHHC9-mediated STAT1 palmitoylation-phosphorylation conversion inhibits gastric cancer progression	10
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”	10
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	10
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”	10
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	10
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors	10
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy	10
Hepatocyte-specific yes-associated protein knockout exacerbates non-alcoholic steatohepatitis by upregulating PCSK9	10
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy	9
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection	9
Acknowledgements	9
Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients	9
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma	9
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study	9
Current status of type 1 (IgG4-related) autoimmune pancreatitis	9
Identification of the distal end of the palisade vessels under sedation: a multicenter prospective study in Japan	9
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer	9
Prognostic value of functional assessment in sarcopenia among pancreatic cancer patients	9
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenoc	8
Clarifying diagnostic scope and future perspectives in AI-assisted diagnosis of Helicobacter pylori infection	8
Cost–utility analysis of treatment strategies for chronic constipation in Japan	8
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease	8
METTL3/YTHDF1 drives M1 macrophage polarization and aggravates ulcerative colitis progression by regulating m6A modification of SerpinB5 mRNA and FBXO32-dependent NF-κB pathway	8
Effects of luseogliflozin on suspected MASLD in patients with diabetes: a pooled meta-analysis of phase III clinical trials	8
Correction: Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction	8
Comment on “Escherichia coli as a gut microbial marker of obesity and its reduction following bariatric treatment”: ecological and functional perspectives	8
Severity of surgical histopathological fibrosis predicted postoperative recurrence in Crohn’s disease: a multi-center retrospective cohort study	8
Differences in adult eosinophilic esophagitis between Japan and Western countries	8
Growing evidence on the highly sensitive iTACT assay of hepatitis B core-related antigen for predicting hepatitis B virus reactivation	8
Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma	8

Serum FGF19 combined with GGT and other biomarkers predicted native liver survival following Kasai portoenterostomy in early biliary atresia	8
Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: a decomposition and age–period–cohort analysis	8
Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study	8
Predictors of lymph node metastases, recurrence, and survival in patients with pedunculated-type T1 colorectal cancer	8
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis	8
RNF207 promotes colorectal cancer growth by regulating the Hippo–YAP pathway via enhanced MST1 ubiquitination and degradation	8
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus	8
Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis	8
HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-dependent HMGCR activation	8
Reply to “Reappraisal of the MASLD predictive factors: insights beyond the surface”	8
Reply to “IL-6 as a biomarker in atezolizumab plus bevacizumab in patients with hepatocellular carcinoma”	8
Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter random	7
Red dichromatic imaging and linked color imaging as reliable image-enhanced endoscopic procedures for detecting the distal end of the palisade vessels in the columnar metaplastic mucosa of the gastroe	7
Long-term evaluation of Helicobacter pylori screening in school health checkups: an 11-year study in Japan	7
Methods to build and maintain effective clinician–patient relationships for adults with disorders of gut–brain interaction (DGBI): a systematic review	7
Correction: Current status and future perspective of linked color imaging for gastric cancer screening: a literature review	7
A decade of clinical course and prognostic determinants in type 1 autoimmune pancreatitis: insights from a 10-year longitudinal multicenter retrospective study	7
Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease	7
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review	7
Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis	7
CACNA2D1 regulates the progression and influences the microenvironment of colon cancer	7
Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCRES	7
A novel artificial intelligence-based endoscopic ultrasonography diagnostic system for diagnosing the invasion depth of early gastric cancer	7
Accounting for resumption timing in evaluating the safety of oral anticoagulants following upper gastrointestinal endoscopic submucosal dissection	7
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases	7
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR	7
Lipidomics and single-cell transcriptomics uncover aberrant lipid metabolism in metaplasia lesions during gastric carcinogenesis	7
Clinical significance of comprehensive genomic profiling in unresectable or recurrent gastrointestinal stromal tumors: a multicenter retrospective cohort study	7
Correction: LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice	7
Profile of plasma microRNAs as a potential biomarker of Wilson’s disease	7
Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasion	7
An endoscopic real-time, in situ assessment of intestinal permeability in type 2 diabetes: links to microbiota and hyperglycemia	7
An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum	7
The vessels encapsulating tumor clusters (VETC) pattern is a negative predictor for first-line immune checkpoint inhibitors alone in unresectable hepatocellular carcinoma	6
Impact of sarcopenia and changes in skeletal muscle mass on prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy with first-line gemcitabine and nab-paclitaxel: a prospec	6
Regulatory mechanism of the RNF168–SCCA1–MYH9 signaling axis in the response of ulcerative colitis	6
Emerging omics diagnosis of perihilar cholangiocarcinoma	6
Did the COVID-19 pandemic disrupt the continuity of post-SVR surveillance in HCV-cured patients?	6
The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia	6
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization	6
Dietary vitamin D intake and risk of colorectal cancer according to vitamin D receptor expression in tumors and their surrounding stroma	6
Comment on “Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan”: methodological considerations regarding causality, subtyp	6
Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas: current understanding and perspectives on malignant progression	6
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia	6
Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N)	6
Letter to the Editor to “Volatomics-based biomarkers for non-invasive diagnosis and monitoring of inflammatory bowel disease”	6
Long-term risk of inflammatory bowel disease in patients with irritable bowel syndrome: the cross-sectional and longitudinal relationship	6
Paired tumor–normal metabolomic profiling reveals alterations in choline phospholipid precursor metabolism in biliary tract cancer	6
Educational interventions to enhance support for balancing work and treatment in inflammatory bowel disease patients	6
A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy	6
Prevalence and clinical impact of latent tuberculosis infection in patients with inflammatory bowel disease in Japan: a retrospective multicenter study by the IBD-Quality team	5
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease	5
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan	5
High-mobility group box 1: friend or foe in pancreatitis	5
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study	5
Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis	5
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease	5
Reply to “Letter to “Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis””	5
The clonal heterogeneity of colon cancer with liver metastases	5
Immune checkpoint inhibitor-related pancreatitis: a comprehensive review of epidemiology, pathophysiology, and management	5
Importance of rectal over colon status in ulcerative colitis remission: the role of microinflammation and mucosal barrier dysfunction in relapse	5
Development and validation of a claims-based algorithm to identify incidents and determine the progression phases of gastric cancer cases in Japan	5
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-a	5
Association of early crystalloid type with mortality and costs in acute pancreatitis: a nationwide cohort study	5
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression	5
Determination of optimal cutoff value of ulcerative colitis intestinal ultrasound index to estimate endoscopic improvement in ulcerative colitis	5
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study	5
Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction	5
Hepatitis B core-related antigen kinetics predict spontaneous HBeAg seroclearance in chronic hepatitis B patients	5
Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes	5
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases	5
Reply to ‘C-CAT's triumph in gastroenterology: the wisdom of cats is infinitely superior’	5
Development of gastric mucosa-associated microbiota in autoimmune gastritis with neuroendocrine tumors	4
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria	4
The 2024 diagnostic criteria for primary sclerosing cholangitis	4
Validation of Baveno VII criteria for recompensation in patients with decompensated cirrhosis treated by laparoscopic splenectomy and azygoportal disconnection	4
Future of gastric cancer elimination through Helicobacter pylori eradication therapy in Japan	4
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicen	4
Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis	4
Letter to the editor to “Long‑term outcome of PDT for local failure after CRT or RT for oesophageal cancer”	4
Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan	4
Formation of the pre-metastatic niche by COL9A1 + cancer-associated fibroblasts via SDC4 engagement promotes multi-organ metastasis in gastric cancer	4
Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI	4
Reply to Letter “Gastric cancer in autoimmune gastritis: ranking the risk” by Prof. Massimo Rugge	4
Validation of the Japanese version of the Esophageal Hypervigilance and Anxiety Scale for esophageal symptoms	4
Reply to “Prognostic value of functional assessment in sarcopenia among pancreatic cancer patients”	4
A phase I/II clinical trial of neoadjuvant docetaxel/oxaliplatin/S‑1 (DOS) combination therapy for gastroesophageal junction adenocarcinoma	4
Does early intervention for infected pancreatic necrosis lead to better clinical outcomes compared to delayed intervention?	4
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices	4
Possibility of determining high quantitative fecal occult blood on stool surface using hyperspectral imaging	4
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort	4
Cox proportional hazards regression reveals more than a 100-fold difference in cancer risk by the length of Barrett’s esophagus in Japan	4
Liver transplantation for gastroenteropancreatic neuroendocrine liver metastasis: optimal patient selection and perioperative management in the era of multimodal treatments	4
Clinical features and endoscopic polyp management of Peutz–Jeghers syndrome: the 2nd nationwide epidemiological survey in Japan	4
Current status of waitlist mortality and transplant probability for adult candidates with chronic end-stage liver disease for deceased donor liver transplantation under the Model for End-Stage Liver D	4